Peritoneal carcinomatosis
Advances in peritoneal carcinomatosis treatment
Research on new therapeutic strategies in the management of peritoneal carcinomatosis, including cytoreduction techniques and intraperitoneal chemotherapy.
Read moreResearch
Advancing oncological scienceAt Quenet-Torrent Institute we drive scientific research to improve oncological treatments. Discover our research lines and contributions to medicine.
Research Lines
Peritoneal carcinomatosis
HIPEC
HIPEC: research on new chemotherapeutic agents
Study of new drugs and combinations to optimize hyperthermic intraperitoneal chemotherapy (HIPEC) in different tumor types.
Read more
PIPAC
PIPAC: ongoing clinical trials
Active participation in multicenter clinical trials on pressurized intraperitoneal aerosol chemotherapy (PIPAC) for peritoneal tumors.
Read more
Research
Two-stage surgery with HIPEC in pseudomyxoma peritonei
Pioneering study demonstrating the feasibility and efficacy of a two-stage surgical strategy with HIPEC for voluminous pseudomyxoma peritonei, achieving complete pathological response in all patients with no mortality.
Read more
Research
What does the PRODIGE 7 study teach us?
The PRODIGE 7 study, led by Prof. Dr. François Quenet, provides fundamental data on the role of HIPEC with oxaliplatin in peritoneal carcinomatosis of colorectal origin.
Read more
Easy Contact
Need to speak with a specialist?
Complete the form and schedule your appointment to speak directly with the surgeon.